ALEXANDRIA, Va., June 17 -- United States Patent no. 12,310,964, issued on May 27, was assigned to Purdue Research Foundation.
"Compositions and methods for the treatment of Lowe Syndrome" was invented by Ruben Claudio Aguilar (West Lafayette, Ind.).
According to the abstract* released by the U.S. Patent & Trademark Office: "A combination of active agents for the treatment of Lowe Syndrome (LS) comprising a RhoA inhibitor and a mTOR inhibitor; a pharmaceutical composition comprising the combination and a pharmaceutically acceptable carrier; a combination of pharmaceutical compositions in which one composition comprises a RhoA inhibitor and the other composition comprises a mTOR inhibitor; and a method of treating a patient for LS."
The p...